Günter Höglinger
Günter Höglinger
Professor for Neurology, Technical University Munich
Verified email at dzne.de
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
autophagy 12 (1), 1-222, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ...
Autophagy 4 (2), 151-175, 2008
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
GU Höglinger, P Rizk, MP Muriel, C Duyckaerts, WH Oertel, I Caille, ...
Nature neuroscience 7 (7), 726-735, 2004
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ...
Movement Disorders 32 (6), 853-864, 2017
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699, 2011
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
GU Höglinger, J Féger, A Prigent, PP Michel, K Parain, P Champy, ...
Journal of neurochemistry 84 (3), 491-502, 2003
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease
GU Höglinger, G Carrard, PP Michel, F Medja, A Lombès, M Ruberg, ...
Journal of neurochemistry 86 (5), 1297-1307, 2003
Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors
B Nait-Oumesmar, N Picard-Riera, C Kerninon, L Decker, D Seilhean, ...
Proceedings of the National Academy of Sciences 104 (11), 4694-4699, 2007
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
GU Höglinger, JJ Breunig, C Depboylu, C Rouaux, PP Michel, ...
Proceedings of the National Academy of Sciences 104 (9), 3585-3590, 2007
Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation
K Ridder, S Keller, M Dams, AK Rupp, J Schlaudraff, D Del Turco, ...
PLoS Biol 12 (6), e1001874, 2014
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe
P Champy, GU Höglinger, J Féger, C Gleye, R Hocquemiller, A Laurens, ...
Journal of neurochemistry 88 (1), 63-69, 2004
Dopamine and adult neurogenesis
A Borta, GU Höglinger
Journal of neurochemistry 100 (3), 587-595, 2007
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases
G Respondek, M Stamelou, C Kurz, LW Ferguson, A Rajput, WZ Chiu, ...
Movement disorders 29 (14), 1758-1766, 2014
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ...
Movement Disorders 29 (4), 470-478, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ...
The Lancet Neurology 13 (7), 676-685, 2014
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger, A Lannuzel, ME Khondiker, PP Michel, C Duyckaerts, ...
Journal of neurochemistry 95 (4), 930-939, 2005
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
F Ros-Bernal, S Hunot, MT Herrero, S Parnadeau, JC Corvol, L Lu, ...
Proceedings of the National Academy of Sciences 108 (16), 6632-6637, 2011
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options
AC Ludolph, J Kassubek, BG Landwehrmeyer, E Mandelkow, ...
European Journal of Neurology 16 (3), 297-309, 2009
Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates
N Freundlieb, C François, D Tandé, WH Oertel, EC Hirsch, GU Höglinger
Journal of Neuroscience 26 (8), 2321-2325, 2006
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
AL Boxer, JT Yu, LI Golbe, I Litvan, AE Lang, GU Höglinger
The Lancet Neurology 16 (7), 552-563, 2017
The system can't perform the operation now. Try again later.
Articles 1–20